In This Article:
In recent weeks, the Australian market has demonstrated resilience, with the ASX200 reaching new highs despite mixed performances across various sectors. While Health Care and Financials have shown strength, Energy and Industrials have lagged behind, highlighting a diverse landscape for investors to navigate. In this context, identifying small-cap stocks with potential insider action can offer unique opportunities for those seeking growth in an evolving market environment.
Top 10 Undervalued Small Caps With Insider Buying In Australia
Name | PE | PS | Discount to Fair Value | Value Rating |
---|---|---|---|---|
GWA Group | 15.9x | 1.5x | 42.58% | ★★★★★★ |
DUG Technology | 53.9x | 2.3x | 49.40% | ★★★★★☆ |
Collins Foods | 18.3x | 0.7x | 3.16% | ★★★★☆☆ |
Dicker Data | 18.8x | 0.7x | -56.10% | ★★★★☆☆ |
Eureka Group Holdings | 18.8x | 6.0x | 26.79% | ★★★★☆☆ |
FINEOS Corporation Holdings | NA | 3.4x | 47.93% | ★★★★☆☆ |
Healius | NA | 0.6x | 11.05% | ★★★★☆☆ |
Tabcorp Holdings | NA | 0.5x | 7.44% | ★★★★☆☆ |
Corporate Travel Management | 24.1x | 2.9x | 40.90% | ★★★☆☆☆ |
Cromwell Property Group | NA | 4.5x | -17.12% | ★★★☆☆☆ |
Let's explore several standout options from the results in the screener.
Healius
Simply Wall St Value Rating: ★★★★☆☆
Overview: Healius is a healthcare company primarily engaged in providing pathology and imaging services, with a market capitalization of A$2.36 billion.
Operations: Healius generates revenue primarily from its Pathology and Imaging segments, contributing A$1.27 billion and A$474.5 million, respectively. The company's gross profit margin has shown a declining trend, reaching 31.00% by the end of 2024. Operating expenses have consistently impacted profitability, with significant non-operating expenses further affecting net income margins negatively over recent periods.
PE: -1.6x
Healius, a smaller player in Australia's healthcare sector, presents an intriguing case for investors seeking overlooked opportunities. Despite recent shareholder dilution and reliance on external borrowing, the company's earnings are projected to soar by 85% annually. Insider confidence is evident with recent share purchases throughout 2024. The sale of Lumus Imaging in September 2024 highlights strategic repositioning efforts. With constitutional amendments approved in November 2024, Healius is poised for potential transformation amidst industry shifts.
-
Delve into the full analysis valuation report here for a deeper understanding of Healius.
-
Understand Healius' track record by examining our Past report.
Infomedia
Simply Wall St Value Rating: ★★★★★★
Overview: Infomedia is a company that specializes in providing software solutions and data analytics for the automotive industry, with a market capitalization of A$0.45 billion.